{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "JW THERAP-B", "longName": "JW (Cayman) Therapeutics Co. Ltd", "messageBoardId": "finmb_677234601", "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "market": "hk_market", "esgPopulated": false, "regularMarketChangePercent": -4.0816355, "regularMarketPrice": 3.29, "marketState": "CLOSED", "firstTradeDateMilliseconds": 1604367000000, "priceHint": 3, "epsTrailingTwelveMonths": -2.31, "epsForward": -1.58, "epsCurrentYear": -1.72, "priceEpsCurrentYear": -1.9127907, "sharesOutstanding": 411036000, "bookValue": 5.717, "fiftyDayAverage": 3.6508, "fiftyDayAverageChange": -0.36080003, "fiftyDayAverageChangePercent": -0.09882766, "twoHundredDayAverage": 4.4352, "twoHundredDayAverageChange": -1.1452003, "twoHundredDayAverageChangePercent": -0.2582071, "marketCap": 1352308480, "forwardPE": -2.0822785, "priceToBook": 0.57547665, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "ipoExpectedDate": "2020-10-28", "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.1400001, "regularMarketTime": 1683878916, "regularMarketDayHigh": 3.45, "regularMarketDayRange": "3.22 - 3.45", "regularMarketDayLow": 3.22, "regularMarketVolume": 241000, "regularMarketPreviousClose": 3.43, "bid": 3.29, "ask": 3.31, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 3.45, "averageDailyVolume3Month": 525554, "averageDailyVolume10Day": 232218, "fiftyTwoWeekLowChange": 0.5899999, "fiftyTwoWeekLowChangePercent": 0.21851848, "fiftyTwoWeekRange": "2.7 - 9.46", "fiftyTwoWeekHighChange": -6.17, "fiftyTwoWeekHighChangePercent": -0.6522199, "fiftyTwoWeekLow": 2.7, "fiftyTwoWeekHigh": 9.46, "earningsTimestamp": 1680088860, "earningsTimestampStart": 1680088860, "earningsTimestampEnd": 1680088860, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "2126.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building B", "address2": "5th Floor No. 699 Zhong Ke Road Pudong New District", "city": "Shanghai", "country": "China", "phone": "86 21 5078 3699", "website": "https://www.jwtherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People's Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.", "fullTimeEmployees": 528, "companyOfficers": [{"maxAge": 1, "name": "Dr. Yiping  Li M.D.", "age": 58, "title": "Co-founder, Exec. Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 832986, "fmt": "832.99k", "longFmt": "832,986"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Xin  Fu", "age": 43, "title": "Sr. VP & CFO", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Cao  Xiaoping Ph.D.", "title": "Sr. VP of Tech Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Shaun Paul  Cordoba Ph.D.", "age": 42, "title": "Sr. VP & Chief Scientific Officer", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Raymond J.  Hage Jr.", "age": 54, "title": "Sr. VP of Corp. Devel.", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Qiong  Wu", "age": 48, "title": "Sr. VP & Chief Commercial Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark J.  Gilbert M.D.", "title": "Sr. Advisor & Acting Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ka Man  Ng A.C.I.S., A.C.S., ACIS, ACS", "age": 44, "title": "Company Sec.", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}